Triphenylbutanamines: Kinesin Spindle Protein Inhibitors with in Vivo Antitumor Activity.
Wang, F., Good, J.A.D., Rath, O., Kaan, H.Y.K., Sutcliffe, O.B., Mackay, S.P., Kozielski, F.(2012) J Med Chem 55: 1511
- PubMed: 22248262 
- DOI: https://doi.org/10.1021/jm201195m
- Primary Citation of Related Structures:  
4A50, 4A51 - PubMed Abstract: 
The human mitotic kinesin Eg5 represents a novel mitotic spindle target for cancer chemotherapy. We previously identified S-trityl-l-cysteine (STLC) and related analogues as selective potent inhibitors of Eg5. We herein report on the development of a series of 4,4,4-triphenylbutan-1-amine inhibitors derived from the STLC scaffold ...